A healthcare company using artificial intelligence to help track and predict the onset of human diseases.
On August 18, 2011 Prognos Health announced receiving a convertible note worth $745, 000 from Tom Nicholson.
June 22, 2021
By working with Mirador to integrate their leading expert determination services and support into our prognosFACTORR platform, our clients can be assured that our analytics or data purchase options on our marketplace are fully de-identified and compliant with HIPAA privacy regulations.
The prognosFACTORR platform has the power to query billions of fully-integrated lab and health records on more than 325 million de-identified patients to answer or uncover key healthcare questions in minutes, not months.
June 22, 2021
June 22, 2021
By working with Mirador to integrate their leading expert determination services and support into our prognosFACTORR platform, our clients can be assured that our analytics or data purchase options on our marketplace are fully de-identified and compliant with HIPAA privacy regulations.
The prognosFACTORR platform has the power to query billions of fully-integrated lab and health records on more than 325 million de-identified patients to answer or uncover key healthcare questions in minutes, not months.
June 9, 2021
The prognosFACTOR® platform has the power to query billions of fully-integrated lab and health records on more than 325 million de-identified patients to answer or uncover key healthcare questions in minutes, not months.
June 9, 2021
June 9, 2021
The prognosFACTOR® platform has the power to query billions of fully-integrated lab and health records on more than 325 million de-identified patients to answer or uncover key healthcare questions in minutes, not months.
On November 27, 2017 Prognos Health announced raising $20.5 million in series C funding from SafeGuard Scientifics, Merck Global Health Innovation Fund, Maywic Select Investments, Hikma Ventures, Hermed Capital, Guardian LifeGuardian Life, and Cigna. The co-founder and CEO of Prognos Health, Sundeep Bhan, made the following statements regarding the company's series C funding: